Table 2.
Prospective | Retrospective | Total | |
---|---|---|---|
Site | N (%) | N (%) | N (%) |
Epistaxis | 4 (66.7) | 8 (22.9) | 12 (29.3) |
GI bleeding | 1 (16.7) | 7 (20.0) | 8 (19.5) |
Joint bleeding | 1 (16.7) | 9 (25.7) | 10 (24.4) |
Menorrhagia | 0 (0.0) | 4 (11.4) | 4 (9.8) |
Other | 0 (0.0) | 4 (11.4) | 4 (9.8) |
Mixed | 0 (0.0) | 3 (8.6) | 3 (7.3) |
Total | 6 (100.0) | 35 (100.0) | 41 (100.0) |
Defined as the most severe symptom, or the source of the most significant morbidity.